טוען...
Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid
The recent discovery of the G(i) protein–coupled receptor GPR109A (HM74A in humans; PUMA-G in mice) as a receptor for nicotinic acid has provided the opportunity to gain greater understanding of the underlying biology contributing to the clinical efficacy (increases in HDL, decreases in VLDL, LDL, a...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
2005
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1297267/ https://ncbi.nlm.nih.gov/pubmed/16322787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI27160 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|